SQZ Biotech raises $72M in Series C funding round
The company will use funding to bring cell therapies into clinic in oncology and autoimmune indications.
Investors see something good brewing in a biotech’s hops-derived type 2 diabetes drug
Don’t get the idea that beer is good for you, but a biotech startup is pinning it hopes on the ability of a derivative of hops, the plant that gives beer its bitter taste, to help people with diabetes lose weight and control their glucose levels. Seattle-based KinDex Pharmaceuticals recently unveiled itself with the announcement […]
presented by
The Healthcare Payments Industry Has a Perception Problem
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.